Need Help? Call 1­-866-­796-­7386
« back to stock screener

  GALT stock: Galectin Therapeutics Inc

Current Rating
Sell

Previous Rating

Buy
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$1.66
Market Cap
98M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
-
P/S
-
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
-27.4K
FCF
-0.4
Op. Margin
-
Net Margin
-
ROE
764.80%
ROI
-
ROA
-101.70%
EPS Growth
-19.40%
Current Ratio
4.6
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Surface Oncology Inc (SURF) $1.20 - - 62.1M Strong Buy
Alimera Sciences Inc (ALIM) $6.16 - - 36.7M Strong Buy
Societal CDMO Inc (SCTL) $1.65 - - 92.4M Strong Buy
Greenrose Holding Company Inc (GNRS) $1.36 - - 23.8M Strong Buy
Cumberland Pharmaceuticals, In (CPIX) $2.52 - - 36.5M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More